Advertisement

Trajectories of Patient-Reported Health Status in Patients With an Implantable Cardioverter Defibrillator

Published:January 05, 2015DOI:https://doi.org/10.1016/j.amjcard.2014.12.035
      To date, no study has assessed the course of patient-reported health status in patients with an implantable cardioverter defibrillator (ICD). Studying health status trajectories and their baseline determinants would permit the identification of patients at risk for poor health outcomes after ICD implantation. A combined cohort of 1,222 patients with an ICD (79% men; age = 61.4 [11.2] years) completed the 12-Item Short-Form Health Survey at baseline and 2 to 3 months and 12 to 14 months after implantation. Latent class analyses were used to identify trajectories and predictors of health status over time. Most health status trajectories showed a stable pattern after short-term follow-up, with differences between trajectories being mainly related to differences in absolute levels of health status. Seven trajectories were identified for physical health status. Being unemployed, symptomatic heart failure, ICD shock, psychotropic medication, negative affectivity, and type D personality were identified as independent determinants of poorer physical health status. For mental health status, 6 trajectories were identified. Younger age, low educational level, symptomatic heart failure, renal failure, no use of ACE inhibitors, psychotropic medication, negative affectivity, and type D personality were identified as independent determinants of poorer mental health status. In conclusion, the population with an ICD seems to be heterogeneous in terms of patient-reported physical and mental health status. Patients with an ICD who present with poor health status and a distressed personality profile should be timely identified and monitored as they may benefit from cardiac rehabilitation in combination with behavioral intervention.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Spertus J.
        Barriers to the use of patient-reported outcomes in clinical care.
        Circ Cardiovasc Qual Outcomes. 2014; 7: 2-4
        • Rumsfeld J.S.
        • Alexander K.P.
        • Goff Jr., D.C.
        • Graham M.M.
        • Ho P.M.
        • Masoudi F.A.
        • Moser D.K.
        • Roger V.L.
        • Slaughter M.S.
        • Smolderen K.G.
        • Spertus J.A.
        • Sullivan M.D.
        • Treat-Jacobson D.
        • Zerwic J.J.
        Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association.
        Circulation. 2013; 127: 2233-2249
        • Anker S.D.
        • Agewall S.
        • Borggrefe M.
        • Calvert M.
        • Jaime Caro J.
        • Cowie M.R.
        • Ford I.
        • Paty J.A.
        • Riley J.P.
        • Swedberg K.
        • Tavazzi L.
        • Wiklund I.
        • Kirchhof P.
        The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials.
        Eur Heart J. 2014; 35: 2001-2009
        • Kao C.W.
        • Friedmann E.
        • Thomas S.A.
        Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators.
        Qual Life Res. 2010; 19: 307-315
        • Piotrowicz K.
        • Noyes K.
        • Lyness J.M.
        • McNitt S.
        • Andrews M.L.
        • Dick A.
        • Hall W.J.
        • Moss A.J.
        • Zareba W.
        Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II.
        Eur Heart J. 2007; 28: 601-607
        • Mastenbroek M.H.
        • Versteeg H.
        • Zijlstra W.P.
        • Meine M.
        • Spertus J.A.
        • Pedersen S.S.
        Disease-specific health status as a predictor of mortality in patients with heart failure: a systematic literature review and meta-analysis of prospective cohort studies.
        Eur J Heart Fail. 2014; (Epub ahead of print)https://doi.org/10.1002/ejhf.1055
        • Mommersteeg P.M.
        • Denollet J.
        • Spertus J.A.
        • Pedersen S.S.
        Health status as a risk factor in cardiovascular disease: a systematic review of current evidence.
        Am Heart J. 2009; 157: 208-218
        • Denollet J.
        • Tekle F.B.
        • Pedersen S.S.
        • van der Voort P.H.
        • Alings M.
        • van den Broek K.C.
        Prognostic importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillator.
        Int J Cardiol. 2013; 167: 2705-2709
        • Pedersen S.S.
        • van den Broek K.C.
        • Erdman R.A.
        • Jordaens L.
        • Theuns D.A.
        Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator.
        Europace. 2010; 12: 1446-1452
        • Versteeg H.
        • van 't Sant J.
        • Cramer M.J.
        • Doevendans P.A.
        • Pedersen S.S.
        • Meine M.
        Discrepancy between echocardiographic and patient-reported health status response to cardiac resynchronization therapy: results of the PSYHEART-CRT study.
        Eur J Heart Fail. 2014; 16: 227-234
        • Ware Jr., J.
        • Kosinski M.
        • Keller S.D.
        A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.
        Med Care. 1996; 34: 220-233
        • Mols F.
        • Pelle A.J.
        • Kupper N.
        Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the Dutch population.
        Qual Life Res. 2009; 18: 403-414
        • Denollet J.
        DS14: standard assessment of negative affectivity, social inhibition, and Type D personality.
        Psychosom Med. 2005; 67: 89-97
        • Denollet J.
        • Pedersen S.S.
        • Vrints C.J.
        • Conraads V.M.
        Predictive value of social inhibition and negative affectivity for cardiovascular events and mortality in patients with coronary artery disease: the type D personality construct.
        Psychosom Med. 2013; 75: 873-881
        • Vermunt J.K.
        • Magidson J.
        Latent GOLD 5.0 Upgrade Manual.
        Statistical Innovations, Belmont2013
        • Pedersen S.S.
        • Theuns D.A.
        • Jordaens L.
        • Kupper N.
        Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation.
        Europace. 2010; 12: 1119-1126
        • van den Broek K.C.
        • Kupper N.
        • van der Voort P.H.
        • Alings M.
        • Denollet J.
        • Nyklicek I.
        Trajectories of perceived emotional and physical distress in patients with an implantable cardioverter defibrillator.
        Int J Behav Med. 2014; 21: 149-159
        • Jaksic N.
        • Aukst-Margetic B.
        • Jakovljevic M.
        Does personality play a relevant role in the placebo effect?.
        Psychiatr Danub. 2013; 25: 17-23
        • Hoogwegt M.T.
        • Kupper N.
        • Jordaens L.
        • Pedersen S.S.
        • Theuns D.A.
        Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator.
        Europace. 2013; 15: 1468-1474
        • Johansen J.B.
        • Pedersen S.S.
        • Spindler H.
        • Andersen K.
        • Nielsen J.C.
        • Mortensen P.T.
        Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients.
        Europace. 2008; 10: 545-551
        • Goode K.M.
        • Nabb S.
        • Cleland J.G.
        • Clark A.L.
        A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic.
        J Card Fail. 2008; 14: 379-387
        • Grigioni F.
        • Carigi S.
        • Grandi S.
        • Potena L.
        • Coccolo F.
        • Bacchi-Reggiani L.
        • Magnani G.
        • Tossani E.
        • Musuraca A.C.
        • Magelli C.
        • Branzi A.
        Distance between patients' subjective perceptions and objectively evaluated disease severity in chronic heart failure.
        Psychother Psychosom. 2003; 72: 166-170
        • Sears S.F.
        • Lewis T.S.
        • Kuhl E.A.
        • Conti J.B.
        Predictors of quality of life in patients with implantable cardioverter defibrillators.
        Psychosomatics. 2005; 46: 451-457
        • Irvine J.
        • Dorian P.
        • Baker B.
        • O'Brien B.J.
        • Roberts R.
        • Gent M.
        • Newman D.
        • Connolly S.J.
        Quality of life in the Canadian implantable defibrillator study (CIDS).
        Am Heart J. 2002; 144: 282-289
        • Passman R.
        • Subacius H.
        • Ruo B.
        • Schaechter A.
        • Howard A.
        • Sears S.F.
        • Kadish A.
        Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.
        Arch Intern Med. 2007; 167: 2226-2232
        • Pedersen S.S.
        • Theuns D.A.
        • Muskens-Heemskerk A.
        • Erdman R.A.
        • Jordaens L.
        Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation.
        Europace. 2007; 9: 675-680
        • Peron E.P.
        • Gray S.L.
        • Hanlon J.T.
        Medication use and functional status decline in older adults: a narrative review.
        Am J Geriatr Pharmacother. 2011; 9: 378-391
        • Habibovic M.
        • Burg M.M.
        • Pedersen S.S.
        Behavioral interventions in patients with an implantable cardioverter defibrillator: lessons learned and where to go from here?.
        Pacing Clin Electrophysiol. 2013; 36: 578-590
        • Berg S.K.
        • Pedersen P.U.
        • Zwisler A.D.
        • Winkel P.
        • Gluud C.
        • Pedersen B.D.
        • Svendsen J.H.
        Comprehensive cardiac rehabilitation improves outcome for patients with implantable cardioverter defibrillator. Findings from the COPE-ICD randomised clinical trial.
        Eur J Cardiovasc Nurs. 2015; 14: 34-44
        • Pelle A.J.
        • van den Broek K.C.
        • Denollet J.
        Interventions in the Context of the Distressed (Type D) Personality.
        in: Dornelas E.A. Stress Proof the Heart: Behavioral Interventions for Cardiac Patients. Springer, New York2012: 167-197